Learning Objectives

• Envision opportunities whereby all members of the global community- individuals, providers, corporations, government, academia, and others- collaborate to reshape the medical enterprise, as well as society norms, to promote health, vitality, longevity, and general welfare.
• Characterize advancements in analytics, medicine, science, and technology and how their growing convergence catalyzed by effective leaders will continue to spark innovation to propel us into the future.
• Contemplate solutions to the cultural, economic, ethical, policy, and structural challenges and other uncertainties posed by innovations in healthcare.
• Implement advancements in healthcare to increase access and improve health outcomes.

Accreditation and Certification

In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) and the Aspen Institute. The Annenberg Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The Annenberg Center designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners/Nurses

The Annenberg Center for Health Sciences at Eisenhower designated this live activity for a maximum of 19.5 ANCC contact hours.

Disclosure Statement

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals with the potential to impact the content of an accredited education activity are expected to identify and reference off-label product use and disclose relevant financial relationships with ACCME-defined ineligible companies.

The Annenberg Center for Health Sciences assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant financial relationships that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Disclosures

• Monica Bertagnolli, MD
  • Advisory Board: Natera, Inc.
• Francis Collins, MD, PhD
  • Board of Directors: ImmunoBrain
• Zeke Emanual, MD, PhD
  • Advisory Board: Dendro Technologies, Clarify Health Solutions, Healthcare Foundry, Link Technologies (ended 2/2025), and Alto Pharmacy Holdings (ended 2/2026)
  • Speakers Bureau: Leigh
  • Grant Support: Bergen Center for Ethics University of Bergen and The Bill and Melinda Gates Foundation
  • Other: Daymark Health, FeelBetter Ltd, Korro, Smirk Health Inc, Cellares Corp, Notable Health, JSL Health Capital, Peterson Center on Healthcare
• Awny Farajallah, MD, FACP
  • Employee: Takeda
• Mary Claire Haver, MD, FACOG, MCP
  • Owner: The Pause Life
• Jessica Jackson, PhD
  • Advisory Board: Beckley Psytech, Teva, and Bristol Myers Squibb
  • Consultant: AugMend Health and Sage/BioGen
  • Other: Johnson & Johnson
• Zayna Khayat, PhD
  • Speakers’ Bureau: BMS Canada (ended 5/2026), J&J Canada (ended 2/2026), and Amgen Canada
• Jessica Knurick, PhD, RDN
  • Consultant: Phenobiome.
• Mohit Manrao
  • Employee: AstraZeneca
• Emeran Mayer, MD
  • Advisory Board: Seed and Pendulum
• Dariush Mozaffarian, MD, DrPH
  • Advisory Board: Branch Venture Partners, Elysium Health, Instacart Health, January Inc, Nourish, WndrHLTH, Brightseed, Calibrate, Filtricine (ended), Season Health (ended), and Validation Institute (ended)
  • Consultant: Amazon Health and Equity: Human Co.
  • Royalties: UpToDate
  • Consultant and Grant Support: Google Health
• Wendy Short Bartie, JD
  • Employee: Bristol Myers Squibb
• Reed Tuckerson, MD, FACP
  • Board of Directors: Henry Schein
• Fyodor Urnov, PhD
  • Consultant: Vertex Pharmaceuticals (ended) and Ionis Pharmaceuticals (ended).
• Vindell Washington, MD, MS
  • Employee: Verily

All of the relevant financial relationships listed above have been mitigated.

All other individuals in a position to control the content of this CE activity have no relevant financial relationships to disclose.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Annenberg Center for Health Sciences Privacy Policy

Annenberg Center for Health Sciences Privacy Policy: Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at https://annenberg.net/pages/privacyPolicy.php